Atorvastatin/levamlodipineAlternative Names: Levamlodipine/atorvastatin
Latest Information Update: 02 Dec 2015
At a glance
- Originator CSPC Ouyi Pharmaceutical
- Class Amides; Antihyperlipidaemics; Antihypertensives; Dihydropyridines; Fatty acids; Fluorobenzenes; Heptanoic acids; Nicotinic-acids; Pyrroles
- Mechanism of Action Calcium channel antagonists; HMG-CoA reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Hyperlipidaemia; Hypertension